Zhao, Tong
Liu, Rui
Han, Qi
Han, Xiaolei
Ren, Juan
Mao, Ming
Lu, Jie
Cong, Lin
Wang, Yongxiang
Tang, Shi
Du, Yifeng
Qiu, Chengxuan
Funding for this research was provided by:
Shandong Provincial Hospital Research Incubation Fund (2023FY007)
Shandong Provincial Key Research and Development Program (2021LCZX03)
NSFC (82001397)
Jinan Science and Technology Bureau (202019187)
National Key Research and Development Program of China (2017YFC1310100)
National Natural Science Foundation of China (81861138008)
Academic Promotion Program of Shandong First Medical University (2019QL020)
Taishan Scholar Program of Shandong Province, China, the Integrated Traditional Chinese and Western Medicine Program in Shandong Province (YXH2019ZXY008)
Brain Science and Brain-like Intelligence Technology Research Projects of China (2021ZD0201801)
Swedish Research Council (2017-05819 and 2020-01574)
Swedish Foundation for International Cooperation in Research and Higher Education (CH2019-8320)
Article History
Received: 15 May 2024
Accepted: 1 August 2024
First Online: 9 August 2024
Declarations
:
: The MIND-China study was approved by the Ethics Committee at Shandong Provincial Hospital in Jinan, Shandong Province. Written informed consent was obtained from the study participants or a proxy in the case of persons with severe cognitive impairment. MIND-China was registered in the Chinese Clinical Trial Registry (registration no.: ChiCTR1800017758).
: The datasets used and/or analyzed during the current study are available from the corresponding author upon reasonable request.
: The authors declare no competing interests.
: None.